Already registered? Need to register? Register
PCSK9 Forum

rss LinkedIn News
rss LinkedIn Latest News Updates

About the PCSK9 Education and Research Forum

PCSK9 Education and Research Forum is the independent resource on PCSK9 science and its translation into critically important new treatments to lower low density lipoprotein cholesterol (LDL-C), which promise to transform the prognosis of millions of patients with hypercholesterolaemia (cholesterol disorders), accelerated atherosclerotic vascular heart disease and a high risk of premature cardiovascular (CV) death and disability.
Aims & ObjectivesMission StatementEditorial BoardPartnership & OutreachForthcoming Meetings
Most viewed

From the Editors

Will CANTOS and REVEAL change how we view the clinical use of PCSK9 inhibitors?Will CANTOS and REVEAL change how we view the clinical use of PCSK9 inhibitors?

Anthony Wierzbicki

Positive topline results from the CANTOS and REVEAL trials might suggest a shift in how we manage dyslipidaemic patients. Prof Anthony Wierzbicki discusses this question.

Read the article

View the video